Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why retail pharmacies are the future of diverse clinical trials

Shelli Pavone
Meds
June 10, 2025
Share
Tweet
Share

The importance of diversity in clinical trials is well-documented, yet unfortunately the lack of diversity still occurs at an alarming rate. As a result, we continue to have less effective treatments, poorer health outcomes, one-size-fits-all medicine that falls short of many patients, and many more negative impacts on health care.

The reason for lack of diversity in clinical trials is similarly known, with language barriers, limited access to health care facilities conducting the trials, mistrust, and concerns about cost and time commitment being among some of the central causes. While the U.S. Census shows that 30 to 40 percent of the population are minorities, industry research shows that 80 percent of clinical trial participants are white and only 45 percent are women.

While the problem is complex and requires an equally comprehensive and long-term solution, there are impactful steps we can take to address the need for more inclusive clinical trials that will ultimately lead to more inclusive treatments.

One of those includes leveraging existing and familiar infrastructure: retail pharmacies.

A large majority of the U.S. population lives within a five-mile distance of a retail pharmacy.

By using local pharmacies, such as Walgreens and CVS, as decentralized clinical trial sites, we can make clinical trials more accessible than ever before. Importantly, hosting trials in local communities increases the likelihood that the trial staff and providers are representative of the local population, eliminating potential issues like language barriers and mistrust.

For example, one retail pharmacy invited more than 17 million customers to participate in local or hybrid research studies—most of whom had never been invited to participate in clinical research before. Out of those customers, 63 percent invited to engage with the trials are women, and of that population, 40 percent identify as non-white and 53 percent are over 60 years old—well above historic industry averages.

Pharmacies provide a familiar, trusted environment.

In 2024, a Coresight Research report found that more than three out of four Americans bought products from drugstores or pharmacy retailers. Because the majority of Americans visit a retail pharmacy every quarter, it is convenient for clinical trial participants to integrate trial activities into their routine pharmacy visits with little to no disruption to daily life. With retention being critical to trial outcomes, we need to increase those that fit seamlessly into participants’ lives—especially if we want to improve inclusivity.

In communities around the country, retail pharmacies play an important role and, as a result, represent a significant opportunity to be used as hubs for patient education and specialized clinical offerings.

Pharmacies have established—and adaptable—infrastructure.

Since most pharmacies already offer services like vaccinations, health screenings, and chronic disease management, they have the facilities and processes that can be adapted for clinical trials. According to Moe Alsumidaie, head of research at CliniBiz, retail pharmacies are uniquely positioned to support decentralized clinical trials due to their ability to incorporate technology and innovative approaches to make trials more patient-centric and efficient.

Health care is complex, and the journey from concept to cure is fraught with challenges. When we overlook or underrepresent patient populations, the repercussions are felt across the board, putting patients at risk. Unfortunately, within this spectrum, women and ethnic minorities bear a disproportionately heavier burden, often facing amplified health disparities due to the absence of tailored solutions. A failure to include these voices in health care innovation not only perpetuates health care inequalities but casts a shadow on the potential of medical advancements.

ADVERTISEMENT

There is work to do, of course, beyond identifying and scaling locations for decentralized clinical trials. But we need to start somewhere; and, when we do, we must ensure the efforts are inclusive of the entire population that new treatments have the potential to help.

Shelli Pavone is a health care executive.

Prev

Why flashy AI tools won't fix health care without real infrastructure

June 10, 2025 Kevin 1
…
Next

Living through injury: one family's journey to the other side

June 10, 2025 Kevin 0
…

Tagged as: Medications

Post navigation

< Previous Post
Why flashy AI tools won't fix health care without real infrastructure
Next Post >
Living through injury: one family's journey to the other side

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Related Posts

  • Understanding why people participate in clinical trials

    Pouria Rostamiasrabadi
  • 13 tips for medical students starting their clinical rotations

    Netana Markovitz
  • For medical students: 20 pearls to honor every clinical rotation

    Ton La, Jr., MD, JD
  • The trials and tribulations of health care delivery

    Michelle Detka
  • The benefits of early clinical exposure in medical education

    Karan Patel
  • Pearls and pitfalls for medical students entering their clinical years

    Garrett K. Berger, PharmD

More in Meds

  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • The anesthesia spectrum: Guiding patients through comfort options in oral surgery

    Dexter Mattox, MD, DMD
  • Most Popular

  • Past Week

    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
  • Recent Posts

    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • It’s time for pain protocols to catch up with the opioid crisis

      Sarah White, APRN | Conditions
    • First impressions happen online—not in your exam room

      Sara Meyer | Social media
    • How locum tenens work helps physicians and APPs reclaim control

      Brian Sutter | Policy
    • The hidden incentives driving frivolous malpractice lawsuits

      Howard Smith, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
  • Recent Posts

    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • It’s time for pain protocols to catch up with the opioid crisis

      Sarah White, APRN | Conditions
    • First impressions happen online—not in your exam room

      Sara Meyer | Social media
    • How locum tenens work helps physicians and APPs reclaim control

      Brian Sutter | Policy
    • The hidden incentives driving frivolous malpractice lawsuits

      Howard Smith, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...